Today on Fox News Live with E.D. Hill, we discussed a new weight loss pill, Acomplia (rimonabant). This pill currently being sold in Europe has been seen by many patients struggling with obesity as a "miracle pill."
Many studies have shown that this medication helps patients loose weight when compared to a placebo. Most of the weight reduction results from patients limiting the number of calories they consume on a daily basis. Acomplia helps to control appetite-- something that for many patients involved in weight reduction programs is a major obstacle to success.
Even though the safety of the medication is being monitored, no major problems have yet been reported. There are some mild side effects that people should be aware of, including nausea, dizziness, anxiety and depression.
Many Europeans have accepted the efficacy of this medication. Sweden, for example, has approved reimbursement of the drug through their public service program.
How does it work? It controls the urge to eat. Many are calling this the "anti munchie effect." Acomplia works in the central nervous system by affecting the cannabioids receptors in the brain. Yes, the same receptors that give people the urge to eat when exposed to marijuana.
